Dr Reddy’s Laboratories Ltd has launched Testosterone Gel, a therapeutic equivalent generic version of AndroGel (testosterone gel) which is approved by the US Food and Drug Administration (USFDA).
The AndroGel brand and generic had US sales of approximately $815.6 million for the most recent twelve months ending in February 2019 according to IQVIA Health, the company said in a release.
Dr Reddy’s testosterone gel is available in a net quantity of 88 g pump which dispenses 20.25 mg of testosterone per actuation. Each metered-dose pump is capable of dispensing 60 metered pump actuations.
Shares of Dr Reddy’s Laboratories were trading at Rs 2,908.20, up 0.15 per cent on the BSE.